Can Anti-Inflammatories after spine surgery reduce opioid use without harming healing?

NCT ID NCT07743606

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial compares two pain management approaches after lumbar spine fusion surgery: standard pain medication alone versus standard care plus a short course of NSAIDs (ketorolac in the hospital and naproxen for a week after discharge). The main question is whether adding NSAIDs affects bone healing, specifically the risk of needing another surgery due to failed fusion. The study also tracks pain medication use, recovery, complications, and patient-reported outcomes to see if NSAIDs can safely reduce opioid reliance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ketorolac and naproxen (NSAIDs)
What this could lead to
If NSAIDs prove safe, they could become a standard part of pain management after spine fusion, potentially reducing opioid use.
What could go wrong
The trial is still in progress, and results may show that NSAIDs increase the risk of failed bone healing, leading to more surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KETOROLAC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rothman Orthopaedic Institute

    Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.